HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

B5 antigen

Also Known As:

B5-antigen

Networked: 9 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Biological Factors: 2472
- Antigens: 143924
  - Neoplasm Antigens: 6217
    - B5 antigen: 9

Related Diseases

1.	Enterovirus Infections 05/01/1988 - "The corresponding figures for 85 sera from enterovirus infections diagnosed by a greater than or equal to 4-fold rise in complement fixing (CF) antibody titre against antigen from ECHO 18 and/or Coxsackie B5 antigen were 10/39, 12/20 and 9/26. " 12/01/1994 - "However, the prevalence of serum polymeric IgA antibodies against coxsackie B5 antigen was significantly greater (P = 0.02) in patients with an acute enterovirus infection (57%) than in patients with other infections (18%). "
2.	Infections 12/01/1994 - "However, the prevalence of serum polymeric IgA antibodies against coxsackie B5 antigen was significantly greater (P = 0.02) in patients with an acute enterovirus infection (57%) than in patients with other infections (18%). "
3.	Neoplasms (Cancer) 05/01/1990 - "The B5 antigen is an integral component of human erythrocyte membranes which becomes enhanced in cancer patients. " 01/01/1987 - "An antigen, 'B5', on erythrocytes has been shown to become enhanced when cancer develops, regardless of tumour type, and thus the B5 antigen may be utilised as a 'universal' tumour marker. " 01/01/1981 - "Cross-reactivity between B5 antigen(s) and tumor-associated antigen was suggested and the nature of the cross-reactivity was discussed. " 04/01/1985 - "The B5 antigen was expressed on some lymphoblastoid B cell lines and B cell neoplasms but was not expressed on leukemias or lymphomas of T or myeloid origin. "
4.	Lymphoma (Lymphomas) 03/01/1997 - "Dogs with lymphoma in which the B5 antigen was expressed below normal levels experienced shorter progression free survival (125 vs. 202 days; p < 0.05) and overall survival times (203 vs. 385 days; p < 0.05) than dogs with B-cell lymphoma in which the B5 antigen was expressed normally. " 04/01/1985 - "The B5 antigen was expressed on some lymphoblastoid B cell lines and B cell neoplasms but was not expressed on leukemias or lymphomas of T or myeloid origin. "
5.	B-Cell Lymphoma (Lymphoma, B Cell) 03/01/1997 - "Dogs with lymphoma in which the B5 antigen was expressed below normal levels experienced shorter progression free survival (125 vs. 202 days; p < 0.05) and overall survival times (203 vs. 385 days; p < 0.05) than dogs with B-cell lymphoma in which the B5 antigen was expressed normally. "

Related Drugs and Biologics

1.	Antibodies
2.	polymeric IgA
3.	Antigens
4.	Cytokines
5.	Complement System Proteins (Complement)